# EDWARDS LIFESCIENCES CORPORATION (EW) FY2026 Q1 Balance Sheet

- Company: EDWARDS LIFESCIENCES CORPORATION (EW)
- Period: As of 2026-03-31
- Filing: Q1 FY2026 10-Q, filed 2026-05-06, accession number 0001099800-26-000026
- Page: https://plicit.ai/financials/ew/fy2026-q1-balance-sheet
- Chart image: https://plicit.ai/charts/ew-fy2026-q1-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 13,321,200,000 US dollars
- **Current assets**: 6,228,700,000 US dollars
- **Non-current assets**: 7,092,500,000 US dollars
- **Liabilities**: 2,993,700,000 US dollars
- **Current liabilities**: 1,409,000,000 US dollars
- **Non-current liabilities**: 1,584,700,000 US dollars
- **Equity**: 10,327,500,000 US dollars
- **Cash and cash equivalents**: 2,445,500,000 US dollars
- **Short-term investments (Note 5)**: 1,226,000,000 US dollars
- **Inventories (Note 2)**: 1,119,000,000 US dollars
- **Accounts receivable, net of allowances of $15.6 and $15.0, respectively**: 775,700,000 US dollars
- **Other current assets**: 329,500,000 US dollars
- **Other receivables**: 197,300,000 US dollars
- **Prepaid expenses**: 135,700,000 US dollars
- **Property, plant, and equipment, net**: 1,823,100,000 US dollars
- **Goodwill**: 1,819,600,000 US dollars
- **Other intangible assets, net**: 1,227,900,000 US dollars
- **Deferred income taxes**: 1,098,100,000 US dollars
- **Other assets (Note 2)**: 738,900,000 US dollars
- **Long-term investments (Note 5)**: 285,600,000 US dollars
- **Operating lease right-of-use assets**: 99,300,000 US dollars
- **Accrued and other liabilities (Note 2)**: 1,203,600,000 US dollars
- **Accounts payable**: 181,100,000 US dollars
- **Operating lease liabilities**: 24,300,000 US dollars
- **Long-term debt**: 598,500,000 US dollars
- **Uncertain tax positions**: 555,400,000 US dollars
- **Other liabilities**: 350,700,000 US dollars
- **Operating lease liabilities**: 80,100,000 US dollars
- **Retained earnings**: 14,621,200,000 US dollars
- **Additional paid-in capital**: 2,781,500,000 US dollars
- **Common stock, $1.00 par value, 1,050.0 shares authorized, 660.0 and 658.7 shares issued, and 577.0 and 580.7 shares outstanding, respectively**: 660,000,000 US dollars
- **Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding**: 0 US dollars
- **Treasury stock, at cost, 83.0 and 78.0 shares, respectively**: negative 7,513,900,000 US dollars
- **Accumulated other comprehensive loss (Note 13)**: negative 221,300,000 US dollars
- **Gross equity (calculated)**: 18,062,700,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.